<DOC>
	<DOCNO>NCT00372853</DOCNO>
	<brief_summary>This study determine high tolerable dose CP-675,206 give combination SU011248 .</brief_summary>
	<brief_title>Dose-Finding Study Of CP-675,206 And SU011248 In Patients With Metastatic Renal Cell Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<mesh_term>Tremelimumab</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Histologically proven renal cell carcinoma metastases Eastern Cooperative Oncology Group ( ECOG ) PS 0 1 Prior treatment one systemic therapy metastatic renal cell carcinoma History know brain metastasis , spinal cord compression carcinomatous meningitis , new evidence brain leptomeningeal disease screen Computed Axial Tomography ( CT ) Magnetic Resonance Imaging ( MRI ) scan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>